Advertisement

Topics

BioCentury Company Profile

19:30 EST 11th December 2018 | BioPortfolio

BioCentury has pioneered the creation of turf-neutral, independent venues for the corporate and investment communities to conduct business. As a result, these events are known by the quality of their audiences and the support of global financial institutions and professional service collaborators.

Contact

Phone: 1 312-755-0798
Email: ericpierce@biocentury.com


News Articles [54 Associated News Articles listed on BioPortfolio]

@BioCentury BioCentury

Acorda loses appeal to shield Ampyra from generic entry https://buff.ly/2wYZhqm 

We're at @BioCentury 26th NewsMakers conference in NYC. Here's a list (PDF) of the Presenting Companies today: https://www.biocentury.com/sites/default/files/NM18schedule.pdf …https://www.biocentury.com/conferences/newsmakers-2018 …

We're at @BioCentury 26th NewsMakers conference in NYC. Here's a list (PDF) of the Presenting Companies today: https://www.biocentury.com/sites/default/files/NM18schedule.pdf … https:/...

@PDRennert Paul D. Rennert

comprehensive SITC writeup with analysis of key IO/IO trials https://www.biocentury.com/biocentury/product-development/2018-11-16/pharmacodynamic-biomarkers-are-driving-io-combos-absence- … (subsc...

@VipinSuri4 Vipin Suri

Great piece @BioCentury on all the various strategies for “souping-up CARs” being presented at #ASH18. Love the schematic figure, and thanks for mentioning @Obsidian_Tx poster #2045 (Sat@6:15PM).

@EMcCallister01 Erin McCallister

5 yrs after members of its own AdComm advised rethinking the CVOT guidance for diabetes drugs, @US_FDA will have a meeting on Oct. 24-25 to do just that. Original story from 2013

@ChinaBiotech Monica

Just want to give a shout out to @BioCentury 's #microbiome whitepaper. Interesting emerging field with implications for immunology, cancer and metabolic diseases. Report is #free to download.

@JMaraganore John Maraganore

Our efforts to bring #innovation to patients requires the best scientists, clinicians, and business leaders from around the world. Anti-#immigrant policies and rhetoric are bad for patients.

@krebs_matt matt krebs

Last week, the #biotech industry raised $1.1B, bringing to $60.9B the total raised YTD. Want to run your own analysis? Chk out our BioCentury BCIQ database: https://bciq.biocentury.com/marketing  ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

BioCentury

BioCentury has pioneered the creation of turf-neutral, independent venues for the corporate and investment communities to conduct business. As a result, these events are known by the quality of their ...

ScarX Therapeutics Corp.

ScarX Therapeutics is a Toronto-based life sciences company founded in partnership with The Hospital for Sick Children and MaRS Innovation, which discovers and develops innovative...

Biotechnology Australia

This century is already being coined the ‘Biocentury', as the fruits of fifty years of research in the field of molecular biology begin to affect our world. Medical advances over the next hundred ye...

More Information about "BioCentury" on BioPortfolio

We have published hundreds of BioCentury news stories on BioPortfolio along with dozens of BioCentury Clinical Trials and PubMed Articles about BioCentury for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioCentury Companies in our database. You can also find out about relevant BioCentury Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record